Cytek Biosciences Reports Fourth Quarter and Full Year 2022 Financial ResultsGlobeNewsWire • 02/28/23
Sale of Flow Cytometry and Imaging Business From DiaSorin to Cytek® Biosciences CompletedGlobeNewsWire • 02/28/23
Cytek® Biosciences to Acquire Flow Cytometry and Imaging Business from DiaSorinGlobeNewsWire • 02/13/23
Cytek Biosciences to Report Fourth Quarter and Full Year 2022 Financial Results on February 28, 2023GlobeNewsWire • 02/07/23
5 Most Cheapest Stocks In The Healthcare Sector: Bio-Techne, Mirati Therapeutics And More - Corcept Therapeutics (NASDAQ:CORT), Cytek Biosciences (NASDAQ:CTKB)Benzinga • 12/15/22
Cytek Biosciences to Report Third Quarter 2022 Financial Results on November 9, 2022GlobeNewsWire • 10/26/22
Cytek to Participate in the 20th Annual Morgan Stanley Global Healthcare ConferenceGlobeNewsWire • 08/30/22
Cytek Biosciences, Inc. (CTKB) CEO Wenbin Jiang on Q2 2022 Results Earnings Call TranscriptSeeking Alpha • 08/11/22
Cytek Biosciences Vs. 10x Genomics: 2 Opposing Cell Visualization InvestmentsSeeking Alpha • 07/27/22
Cytek to Participate in the 42nd Annual Canaccord Genuity Global Growth ConferenceGlobeNewsWire • 07/21/22
Cytek Biosciences to Report Second Quarter 2022 Financial Results on August 10, 2022GlobeNewsWire • 07/20/22
Cytek® Biosciences Receives CE Marking for Series of cFluor® Reagents, TBNK KitGlobeNewsWire • 05/24/22
Cytek Biosciences, Inc. (CTKB) CEO Wenbin Jiang on Q1 2022 Results - Earnings Call TranscriptSeeking Alpha • 05/12/22